About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half ...
Most adults (62%) say they have taken a GLP-1 drug to treat a chronic condition including diabetes or heart disease, while 43 ...
A NEW weight loss drug could hijack the brain like a ‘Trojan horse’ to double weight loss. The drug could help the body to ...
Injected medications that treat diabetes and obesity increase the risk of a rare but serious side effect: stomach paralysis, ...
GLP-1 agonists have ushered in a new era in anti-obesity medication policy considerations against the backdrop of a continued focus by policymakers on both drug access and pricing. CMS has taken steps ...
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill ...
As the global focus on health and weight management intensifies, Nestle has announced the launch of Vital Pursuit, a brand ...
Wegovy, Ozempic and now retatrutide – the ‘miracle’ drugs are booming, but are they safe and how do they stack up?
Diabetes is a key risk factor for kidney disease, which is one of the leading causes of death in the United States and ...
It’s hard to watch TV these days without seeing an article or ad praising weight-loss wonder drugs. Some of these drugs, like ...
More than 40% of adults in the United States live with obesity, and the percentage of people living with obesity continues to increase dramatically. While experts have learned a great deal about the ...
(MENAFN- The Conversation) Obesity levels for adults have hit 26% in Britain and 42.5% in the United States, journalist Johann Hari writes in his new book, Magic Pill . In Australia, recent data shows ...